Trials / Completed
CompletedNCT02275312
ETREAT Study on Effectiveness of Botulinum Toxin Type A Injections to Treat Post-stroke Upper and/or Lower Limb Spasticity
ETREAT: A Prospective Observational Study to Evaluate the Effectiveness of Botulinum Toxin Type A (BoNT-A) Injections in Patients With Post-stroke Upper and/or Lower Limb Spasticity in the Early Stage of Spasticity Development.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 110 (actual)
- Sponsor
- Ipsen · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the effectiveness of BoNT-A on functional improvement in patients with post-stroke upper and/or lower limb spasticity in the early stage of spasticity development, according to routine clinical practice.
Conditions
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2017-07-01
- Completion
- 2017-07-01
- First posted
- 2014-10-27
- Last updated
- 2019-08-16
Locations
17 sites across 1 country: Spain
Source: ClinicalTrials.gov record NCT02275312. Inclusion in this directory is not an endorsement.